📰 Genentech News
Page 127 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
July 20, 2023
Neuroscientist considered to be ‘leader among leaders’ was found to have exhibited substandard scientific practices
July 20, 2023
The review refuted the most serious claim involving Dr Tessier-Lavigne’s work, that an important 2009 Alzheimer’s study was the subject of an investigation that found falsified data and that Dr Tessier-Lavigne had covered it up
July 20, 2023
Late-breaking post-hoc data indicate Vabysmo leads to less fibrosis, which may negatively impact vision, than aflibercept in people with diabetic macular edema Real-world data reinforce that...
July 20, 2023
The president of Stanford and the head football coach at Northwestern left their positions after being scrutinized in campus newspapers.
July 20, 2023
Marc Tessier-Lavigne was cleared of participation in research misconduct after concerns arose over data manipulation.
July 20, 2023
Marc Tessier-Levigne subjected his scientific work to months of intense scrutiny declared On Wednesday he resigned as president of Stanford University
July 20, 2023
‒ Late-breaking post-hoc data indicate Vabysmo leads to less fibrosis, which may negatively impact vision, than aflibercept in people with diabetic macular edema (DME) – ‒ Real-world data reinforce that first-line
July 20, 2023
Late-breaking post-hoc data indicate Vabysmo leads to less fibrosis, which may negatively impact vision, than aflibercept in people with diabetic macular edema (DME)Real-world data reinforce that first-line Vabysmo use
July 20, 2023
Marc Tessier-Lavigne had one of the most stellar reputations in academia
July 20, 2023
‒ Late-breaking post-hoc data indicate Vabysmo leads to less fibrosis, which may negatively impact vision, than aflibercept in people with diabetic macular edema (DME) –‒ Real-world data reinforce that first-line Vabysmo use improves outcomes and extends treatment intervals rapidly during the first four months for p...